Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors
NCT01632696
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision
Conditions
Malignant Solid Tumor
Interventions
DRUG:
I-124 PGN650 for PET/CT
Sponsor
Peregrine Pharmaceuticals